{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:42:58Z","timestamp":1791582178808,"version":"4.3.4"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP14\/00121"],"award-info":[{"award-number":["CP14\/00121"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CPII19\/00001"],"award-info":[{"award-number":["CPII19\/00001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00337"],"award-info":[{"award-number":["PI16\/00337"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00210"],"award-info":[{"award-number":["PI18\/00210"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00301"],"award-info":[{"award-number":["PI19\/00301"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background &amp; aims<\/jats:title>\n<jats:p>HCV CD4+ and CD8+ specific T cells responses are functionally impaired during chronic hepatitis C infection. DAAs therapies eradicate HCV infection in more than 95% of treated patients. However, the impact of HCV elimination on immune responses remain controversial. Here, we aimed to investigate whether HCV cure by DAAs could reverse the impaired immune response to HCV.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We analyzed 27 chronic HCV infected patients undergoing DAA treatment in tertiary care hospital, and we determined the phenotypical and functional changes in both HCV CD8+ and CD4+ specific T-cells before and after viral clearance. PD-1, TIM-3 and LAG-3 cell-surface expression was assessed by flow cytometry to determine CD4+ T cell exhaustion. Functional responses to HCV were analyzed by IFN-\u0194 ELISPOT, intracellular cytokine staining (IL-2 and IFN-\u0194) and CFSE-based proliferation assays.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>We observed a significant decrease in the expression of PD-1 in CD4+ T-cells after 12 weeks of viral clearance in non-cirrhotic patients (p = 0.033) and in treatment-naive patients (p = 0.010), indicating a partial CD4 phenotype restoration. IFN-\u0194 and IL-2 cytokines production by HCV-specific CD4+ and CD8+ T cells remained impaired upon HCV eradication. Finally, a significant increase of the proliferation capacity of both HCV CD4+ and CD8+ specific T-cells was observed after HCV elimination by DAAs therapies.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our results show that in chronically infected patients HCV elimination by DAA treatment lead to partial reversion of CD4+ T cell exhaustion. Moreover, proliferative capacity of HCV-specific CD4+ and CD8+ T cells is recovered after DAA\u2019s therapies.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0254243","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T18:29:23Z","timestamp":1625855363000},"page":"e0254243","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy"],"prefix":"10.1371","volume":"16","author":[{"given":"Meritxell","family":"Llorens-Revull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Costafreda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Guerrero-Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"P\u00edriz-Ruzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Vargas-Accarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Gabriel-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Rodr\u00edguez-Fr\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Riveiro-Barciela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Perales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Quer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sauleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6103-072X","authenticated-orcid":true,"given":"Marta","family":"Bes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"issue":"1","key":"pone.0254243.ref001","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies","volume":"13","author":"JM Micallef","year":"2006","journal-title":"J Viral Hepat"},{"issue":"2","key":"pone.0254243.ref002","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression","volume":"48","author":"HH Thein","year":"2008","journal-title":"Hepatology"},{"issue":"7350","key":"pone.0254243.ref003","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/474S2a","article-title":"Introduction: A smouldering public-health crisis","volume":"474","author":"L Gravitz","year":"2011","journal-title":"Nature [Internet]"},{"issue":"4","key":"pone.0254243.ref004","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/cells8040317","article-title":"Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection","volume":"8","author":"JL Casey","year":"2019","journal-title":"Cells"},{"issue":"4","key":"pone.0254243.ref005","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","article-title":"Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy","volume":"65","author":"M Reig","year":"2016","journal-title":"J Hepatol"},{"issue":"3","key":"pone.0254243.ref006","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2016.05.010","article-title":"Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study","volume":"65","author":"LS Belli","year":"2016","journal-title":"J Hepatol [Internet]"},{"issue":"10","key":"pone.0254243.ref007","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection","volume":"194","author":"R Thimme","year":"2001","journal-title":"J Exp Med"},{"issue":"12","key":"pone.0254243.ref008","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function","volume":"188","author":"AJ Zajac","year":"1998","journal-title":"J Exp Med"},{"issue":"4","key":"pone.0254243.ref009","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0016-5085(99)70353-7","article-title":"Recurrence of hepatitis C virus after loss of virus-specific CD4+ T- cell response in acute hepatitis C","volume":"117","author":"JT Gerlach","year":"1999","journal-title":"Gastroenterology"},{"issue":"4","key":"pone.0254243.ref010","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1053\/j.gastro.2008.12.034","article-title":"Analysis of CD8 + T-Cell-Mediated Inhibition of Hepatitis C Virus Replication Using a Novel Immunological Model","volume":"136","author":"J Jo","year":"2009","journal-title":"Gastroenterology"},{"key":"pone.0254243.ref011","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-3-642-27340-7_10","volume-title":"Hepatitis C Virus: From Molecular Virology to Antiviral Therapy [Internet]","author":"C Neumann-Haefelin","year":"2013"},{"issue":"4","key":"pone.0254243.ref012","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus","volume":"10","author":"S Cooper","year":"1999","journal-title":"Immunity"},{"issue":"5645","key":"pone.0254243.ref013","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help","volume":"302","author":"A Grakoui","year":"2003","journal-title":"Science (80-)"},{"issue":"9","key":"pone.0254243.ref014","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus","volume":"191","author":"F Lechner","year":"2000","journal-title":"J Exp Med"},{"issue":"7053","key":"pone.0254243.ref015","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04079","article-title":"Adaptive immune responses in acute and chronic hepatitis C virus infection","volume":"436","author":"DG Bowen","year":"2005","journal-title":"Nature [Internet]"},{"key":"pone.0254243.ref016","first-page":"6","article-title":"Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation","author":"B Bengsch","year":"2010","journal-title":"PLoS Pathog"},{"issue":"9","key":"pone.0254243.ref017","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ni1241","article-title":"T cells and viral persistence: Lessons from diverse infections","volume":"6","author":"P Klenerman","year":"2005","journal-title":"Nat Immunol"},{"issue":"11","key":"pone.0254243.ref018","first-page":"645","volume":"10","author":"H Luxenburger","year":"2018","journal-title":"HCV-Specific T Cell Responses During and After Chronic HCV Infection. Viruses"},{"issue":"2017","key":"pone.0254243.ref019","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.antiviral.2017.08.016","article-title":"Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing","volume":"146","author":"MH van der Ree","year":"2017","journal-title":"Antiviral Res [Internet]"},{"issue":"3","key":"pone.0254243.ref020","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2014.05.043","article-title":"Restoration of HCV-specific CD8+ T cell function by interferon-free therapy","volume":"61","author":"B Martin","year":"2014","journal-title":"J Hepatol [Internet]"},{"issue":"7","key":"pone.0254243.ref021","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/gut.2005.080077","article-title":"Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance","volume":"55","author":"A Folgori","year":"2006","journal-title":"Gut"},{"issue":"May","key":"pone.0254243.ref022","first-page":"1","article-title":"TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation.","volume":"8","author":"D Wieland","year":"2017","journal-title":"Nat Commun [Internet]"},{"issue":"8","key":"pone.0254243.ref023","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/infdis\/jiz291","article-title":"Dynamic Changes in Ex Vivo T-Cell Function After Viral Clearance in Chronic HCV Infection","volume":"220","author":"JW Han","year":"2019","journal-title":"J Infect Dis"},{"issue":"12","key":"pone.0254243.ref024","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/jvh.12465","article-title":"Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals","volume":"22","author":"MA Burchill","year":"2015","journal-title":"J Viral Hepat"},{"issue":"5","key":"pone.0254243.ref025","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jhep.2019.06.025","article-title":"Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses","volume":"71","author":"A Aregay","year":"2019","journal-title":"J Hepatol"},{"key":"pone.0254243.ref026","article-title":"Characterising HCV specific CD4+ T\u2010cells following viral\u2010vectored vaccination, directly acting anti\u2010virals and spontaneous viral cure","author":"F Hartnell","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"pone.0254243.ref027","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jhep.2011.11.011","article-title":"T cell responses and viral variability in blood donation candidates with occult hepatitis B infection","volume":"56","author":"M Bes","year":"2012","journal-title":"J Hepatol"},{"issue":"4","key":"pone.0254243.ref028","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2893.2011.01549.x","article-title":"Reversal of nonstructural protein 3-specific CD4 + T cell dysfunction in patients with persistent hepatitis C virus infection","volume":"19","author":"M Bes","year":"2012","journal-title":"J Viral Hepat"},{"issue":"8","key":"pone.0254243.ref029","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Joseph N. Blattman, Kaja Murali-Krishna, Robbert van der Most and RA. Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment","volume":"77","author":"E. John Wherry","year":"2003","journal-title":"J Virol [Internet]"},{"issue":"4","key":"pone.0254243.ref030","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2567.2010.03255.x","article-title":"T-cell exhaustion: Characteristics, causes and conversion","volume":"129","author":"JS Yi","year":"2010","journal-title":"Immunology"},{"issue":"8","key":"pone.0254243.ref031","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"EJ Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"pone.0254243.ref032","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virol.2014.12.033","article-title":"T cell exhaustion during persistent viral infections","volume":"479\u2013480","author":"SM Kahan","year":"2015","journal-title":"Virology"},{"issue":"2","key":"pone.0254243.ref033","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/hepr.13278","article-title":"Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with hepatitis C virus infection","volume":"49","author":"T Watanabe","year":"2019","journal-title":"Hepatol Res"},{"issue":"4","key":"pone.0254243.ref034","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","article-title":"AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis","volume":"7","author":"A Loaeza-del-Castillo","year":"2008","journal-title":"Ann Hepatol"},{"issue":"3","key":"pone.0254243.ref035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jmv.25310","article-title":"Rapid hepatitis C virus clearance by antivirals correlates with immune status of infected patients","volume":"91","author":"R Sasaki","year":"2019","journal-title":"J Med Virol"},{"issue":"4","key":"pone.0254243.ref036","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents","volume":"153","author":"F Kanwal","year":"2017","journal-title":"Gastroenterology [Internet]"},{"issue":"11","key":"pone.0254243.ref037","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/jvh.13167","article-title":"Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virological response","volume":"26","author":"N Peleg","year":"2019","journal-title":"J Viral Hepat"},{"issue":"3","key":"pone.0254243.ref038","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2017.09.016","article-title":"Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine","volume":"68","author":"N Fujiwara","year":"2018","journal-title":"J Hepatol [Internet]"},{"issue":"2","key":"pone.0254243.ref039","first-page":"1","article-title":"Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance","volume":"12","author":"C Zhang","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"pone.0254243.ref040","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2249.1997.4581355.x","article-title":"Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection","volume":"109","author":"J Corado","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"pone.0254243.ref041","first-page":"2019","article-title":"Immunological Dynamics Associated with Direct-Acting Antiviral Therapies in Naive and Experimented HCV Chronic-Infected Patients","author":"GL Pereira","year":"2019","journal-title":"Mediators Inflamm"},{"issue":"12","key":"pone.0254243.ref042","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/infdis\/jiw457","article-title":"Direct-acting antiviral-induced hepatitis c virus clearance does not completely restore the altered cytokine and chemokine milieu in patients with chronic hepatitis c","volume":"214","author":"J Hengst","year":"2016","journal-title":"J Infect Dis"},{"key":"pone.0254243.ref043","first-page":"1","author":"Ji Won Han","year":"2018","journal-title":"Dynamic Changes in Ex Vivo T-Cell Function after Viral Clearance in Chronic HCV Infection"},{"issue":"3","key":"pone.0254243.ref044","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1189\/jlb.2RI0317-097R","article-title":"Transcriptional and epigenetic regulation of T cell hyporesponsiveness","volume":"102","author":"RM Pereira","year":"2017","journal-title":"J Leukoc Biol"},{"issue":"7","key":"pone.0254243.ref045","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.4049\/jimmunol.172.7.4204","article-title":"Maintenance, Loss, and Resurgence of T Cell Responses During Acute, Protracted, and Chronic Viral Infections","volume":"172","author":"MJ Fuller","year":"2004","journal-title":"J Immunol"},{"issue":"6","key":"pone.0254243.ref046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1008181","article-title":"Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals","volume":"15","author":"S Perez","year":"2019","journal-title":"PLoS Genet"},{"issue":"8","key":"pone.0254243.ref047","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2019.02.038","article-title":"HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response","volume":"156","author":"N Hamdane","year":"2019","journal-title":"Gastroenterology [Internet]"},{"issue":"6","key":"pone.0254243.ref048","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2010.06.011","article-title":"HLA class i allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infection","volume":"53","author":"CM Lange","year":"2010","journal-title":"J Hepatol [Internet]."},{"issue":"11","key":"pone.0254243.ref049","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1128\/JVI.79.11.6976-6983.2005","article-title":"Strain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection","volume":"79","author":"K Sugimoto","year":"2005","journal-title":"J Virol"},{"issue":"18","key":"pone.0254243.ref050","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1007\/s00018-013-1344-y","article-title":"Phenotypic and functional alterations of primary human PBMCs induced by HCV non-enveloped capsid-like particles uptake","volume":"70","author":"PP Doumba","year":"2013","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"pone.0254243.ref051","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/cmi.2014.119","article-title":"Hepatitis C virus core protein triggers expansion and activation of CD4+CD25+regulatory T cells in chronic hepatitis C patients","volume":"12","author":"N Zhai","year":"2015","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"pone.0254243.ref052","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/505714","article-title":"Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: Implications for vaccine design","volume":"194","author":"S Smyk-Pearson","year":"2006","journal-title":"J Infect Dis"},{"issue":"8981","key":"pone.0254243.ref053","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0140-6736(95)91691-1","article-title":"Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection","volume":"346","author":"HM Diepolder","year":"1995","journal-title":"Lancet"},{"issue":"Who 2017","key":"pone.0254243.ref054","first-page":"a036921","article-title":"Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy","author":"F Negro","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"pone.0254243.ref055","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/hep.22534","article-title":"High incidence of hepatitis C virus reinfection in a cohort of injecting drug users","volume":"48","author":"CK Aitken","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"pone.0254243.ref056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1411-9","article-title":"The case for a universal hepatitis C vaccine to achieve hepatitis C elimination","volume":"17","author":"N Scott","year":"2019","journal-title":"BMC Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T18:30:38Z","timestamp":1625855438000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254243"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Kanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0254243","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]}}}